Priming Mesenchymal Stem Cells with Endothelial Growth Medium Boosts Stem Cell Therapy for Systemic Arterial Hypertension
Systemic arterial hypertension (SAH), a clinical syndrome characterized by persistent elevation of arterial pressure, is often associated with abnormalities such as microvascular rarefaction, defective angiogenesis, and endothelial dysfunction. Mesenchymal stem cells (MSCs), which normally induce an...
Main Authors: | Lucas Felipe de Oliveira, Thalles Ramos Almeida, Marcus Paulo Ribeiro Machado, Marilia Beatriz Cuba, Angélica Cristina Alves, Marcos Vinícius da Silva, Virmondes Rodrigues Júnior, Valdo José Dias da Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2015/685383 |
Similar Items
-
Mesenchymal Stem Cells & Endothelial Function
by: Kenneth M. Fish, et al.
Published: (2015-05-01) -
Boosting the Biogenesis and Secretion of Mesenchymal Stem Cell-Derived Exosomes
by: Jinli Wang, et al.
Published: (2020-03-01) -
GVHD-derived plasma as a priming strategy of mesenchymal stem cells
by: Amandda Évelin Silva-Carvalho, et al.
Published: (2020-04-01) -
Corneal endothelial expansion promoted by human bone marrow mesenchymal stem cell-derived conditioned medium.
by: Makiko Nakahara, et al.
Published: (2013-01-01) -
Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells
by: Nicole Aaron, et al.
Published: (2021-06-01)